Jörn Schattenberg

141PUBLICATIONS
382CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical parasitologyMedical biochemistry - lipidsPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (141)

|Jul 31, 2026
Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure International Expert Position Paper.

|Jul 29, 2026
Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 Subset.

|Jul 24, 2026
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.

|Jul 22, 2026
Letter: Major Adverse Outcomes in Steatotic Liver Disease Subtypes-From Etiological Classification to Biological Phenotyping.

|Jul 22, 2026
Understanding the economic and healthcare burden of metabolic dysfunction-associated steatohepatitis: a real-world claims data analysis from Germany.

|Jun 03, 2026
Letter: Therapeutic Targeting of PPARs in PBC-Additional Considerations. Authors' Reply.

Pageof 24

Frequent Collaborators

18 joint publications

Joachim Labenz

14 joint publications

Quentin M Anstee

11 joint publications

Jeffrey V Lazarus

10 joint publications

Vincent Wai-Sun Wong